ABUS
Arbutus Biopharma Corporation
$2.78
Earnings Summary
Revenue | $2.15Mn |
Net Profits | $-19.31Mn |
Net Profit Margins | -900.33% |
Highlights
Arbutus Biopharma Corporation’s revenue fell -65.65% since last year same period to $2.15Mn in the Q4 2023. On a quarterly growth basis, Arbutus Biopharma Corporation has generated -53.95% fall in its revenue since last 3-months.
Arbutus Biopharma Corporation’s net profit jumped 15.71% since last year same period to $-19.31Mn in the Q4 2023. On a quarterly growth basis, Arbutus Biopharma Corporation has generated 3.94% jump in its net profits since last 3-months.
Arbutus Biopharma Corporation’s net profit margin fell -145.41% since last year same period to -900.33% in the Q4 2023. On a quarterly growth basis, Arbutus Biopharma Corporation has generated -108.6% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Arbutus Biopharma Corporation post its latest quarter earnings
EPS Estimate Current Quarter | -0.11 |
EPS Estimate Current Year | -0.11 |
Highlights
Arbutus Biopharma Corporation’s earning per share (EPS) estimates for the current quarter stand at -0.11 - a 8.33% jump from last quarter’s estimates.
Arbutus Biopharma Corporation’s earning per share (EPS) estimates for the current year stand at -0.11.
Key Ratios
Key ratios of the Arbutus Biopharma Corporation post its Q4 2023 earnings
Earning Per Share (EPS) | -0.12 |
Highlights
Arbutus Biopharma Corporation’s earning per share (EPS) jumped 14.29% since last year same period to -0.12 in the Q4 2023. This indicates that the Arbutus Biopharma Corporation has generated 14.29% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-07 | -0.11 | -0.12 | -9.09% |
2024-03-05 | -0.12 | -0.12 | 0% |
2023-05-04 | -0.14 | -0.1 | 28.57% |
2023-08-03 | -0.11 | -0.1 | 9.09% |
₹0 US Stocks a/c Opening Fee